Research ArticleANTIMICROBIALS

New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability

See allHide authors and affiliations

Science Translational Medicine  06 Sep 2017:
Vol. 9, Issue 406, eaah6813
DOI: 10.1126/scitranslmed.aah6813

Article Information

vol. 9 no. 406

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 31, 2016
  • Resubmitted February 6, 2017
  • Accepted for publication April 13, 2017
  • .

Author Information

  1. Joseph A. Kirk1,
  2. Dana Gebhart2,
  3. Anthony M. Buckley3,
  4. Stephen Lok2,
  5. Dean Scholl2,
  6. Gillian R. Douce3,
  7. Gregory R. Govoni2,* and
  8. Robert P. Fagan1,*
  1. 1Krebs Institute, Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield S10 2TN, UK.
  2. 2AvidBiotics Corp., South San Francisco, CA 94080, USA.
  3. 3Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK.
  1. *Corresponding author. Email: ggovons{at}gmail.com (G.R.G.); r.fagan{at}sheffield.ac.uk (R.P.F.)

Altmetric

Article usage

Article usage: September 2017 to March 2020

AbstractFullPdf
Sep 20176792245458
Oct 201743442104
Nov 20172622532
Dec 20172161428
Jan 20182262531
Feb 20181772329
Mar 20182481525
Apr 20181632722
May 20182021720
Jun 2018163815
Jul 20181322219
Aug 2018952717
Sep 20181111140
Oct 2018028046
Nov 2018027330
Dec 2018025937
Jan 2019122839
Feb 20191021148
Mar 2019115636
Apr 201928034
May 201959138
Jun 201966316
Jul 201916622
Aug 201924619
Sep 201915826
Oct 2019310335
Nov 201936639
Dec 201929129
Jan 202048833
Feb 202078340
Mar 202016523

Stay Connected to Science Translational Medicine

Navigate This Article